Company

BioMérieux SA

Headquarters: Marcy l'Etoile, France

Employees: 13,000

CEO: Mr. Alexandre Merieux

Euronext: BIM +0.79%

Market Cap

€11.88 Billion

EUR as of Jan. 1, 2024

US$13.12 Billion

Market Cap History

BioMérieux SA market capitalization over time

Evolution of BioMérieux SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of BioMérieux SA

Detailed Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for private and hospital laboratories for the diagnosis of infectious diseases. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

BioMérieux SA has the following listings and related stock indices.


Stock: Euronext: BIM wb_incandescent

Stock: FSX: EYWN wb_incandescent

Details

Headquarters:

376 Chemin De l’Orme

Marcy l'Etoile, 69280

France

Phone: 33 4 78 87 20 00

Fax: 33 4 78 87 20 90